G2TT
来源类型Report
规范类型报告
来源IDRR-326-MERCK
Mapping Pathways: Developing evidence-based, people-centred strategies for the use of antiretrovirals as prevention
Molly Morgan Jones
发表日期2013-06-19
出版年2013
页码129
语种英语
结论
  • Structural factors such as cost and access are as important as individual behaviours.
  • Policymakers and communities need more information to develop successful local strategies.
  • Local context shapes perception: the same scientific data will be viewed and interpreted differently by stakeholders in different countries and groups.
  • The science is dynamic and fast-changing. Providing insight from diverse communities and stakeholders will enrich policies to ensure that ARVs can reach their prevention potential at local and global levels.
摘要

Mapping Pathways is a multinational project to develop and nurture a research-driven, community-led global understanding of the emerging evidence base around the adoption of antiretroviral (ARV)-based prevention strategies to end the HIV/AIDS epidemic. The project is based on the premise that the current array of prevention options is not sufficient; new pathways to prevention, based on enhanced assessment and analysis of likely impact, are needed to address new infections adequately.

,

ARVs are opening up new options for HIV prevention, such as 'treatment as prevention' (often referred to as 'TLC+' [testing, linkage to care], plus treatment), microbicides, oral pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). There are multifaceted challenges associated with these new prevention strategies related to access, cost, behavioural and health impacts, and implementation.

,

Mapping Pathways: Developing evidence-based, people-centred strategies for the use of antiretrovirals as prevention is designed to support critical thinking and development of a new research agenda for the analysis of multiple policy options — the pathways — that should be considered by prevention planners, programmers and funders when addressing the opportunities and challenges of the new ARV paradigm.

目录
  • Chapter One

    The Mapping Pathways journey: snapshots from the beginning

  • Chapter Two

    Snapshots from the empirical literature

  • Chapter Three

    Snapshots from the grassroots evidence base

  • Chapter Four

    Snapshots from the grasstops evidence base

  • Chapter Five

    Snapshots from the ExpertLens survey

  • Chapter Six

    An integrated perspective: how to map pathways to good decisionmaking

主题Evidence Based Health Practice ; HIV and AIDS ; HIV Treatment ; Pharmaceutical Drugs
URLhttps://www.rand.org/pubs/research_reports/RR326.html
来源智库RAND Corporation (United States)
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/522287
推荐引用方式
GB/T 7714
Molly Morgan Jones. Mapping Pathways: Developing evidence-based, people-centred strategies for the use of antiretrovirals as prevention. 2013.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
RAND_RR326.pdf(6154KB)智库出版物 限制开放CC BY-NC-SA浏览
x1495315143923.jpg.p(6KB)智库出版物 限制开放CC BY-NC-SA浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Molly Morgan Jones]的文章
百度学术
百度学术中相似的文章
[Molly Morgan Jones]的文章
必应学术
必应学术中相似的文章
[Molly Morgan Jones]的文章
相关权益政策
暂无数据
收藏/分享
文件名: RAND_RR326.pdf
格式: Adobe PDF
文件名: x1495315143923.jpg.pagespeed.ic.Ql8KHHNf4k.jpg
格式: JPEG

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。